Who counts as related is the data provider's judgement, not a screen run here — there's no ranking implied, and no suggestion these are comparable investments. Changes are for the latest completed session.
Data as of 8/4/26, 5:06 PM (cached up to 30 seconds) · updates automatically while this page is open, during market hours
Company
Pharmaceuticals
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Market cap $1.06TExchange NEW YORK STOCK EXCHANGE, INC.IPO 1970-07-09Country USSector PHARMACEUTICAL PREPARATIONSEmployees 50,000 Website ↗
P/E P/E Price-to-earnings: share price divided by earnings per share. Higher values mean investors are paying more per dollar of current profit. 41.97
P/S P/S Price-to-sales: market value divided by annual revenue. Often used when a company has little or no profit. 14.68
P/B P/B Price-to-book: market value divided by the accounting value of net assets. 27.85
EPS (TTM) EPS (TTM) Earnings per share over the trailing twelve months — profit divided by shares outstanding. 28.15
Beta Beta How much the share price has moved relative to the wider market. Around 1 means it moved roughly in line; above 1 means larger swings, below 1 smaller. 0.45
ROE ROE Return on equity: profit as a percentage of shareholders’ equity — how efficiently the company turns equity into profit. 101.3%
Gross margin Gross margin Gross profit as a percentage of revenue — what’s left after the direct cost of producing the product. 82.8%
Operating margin Operating margin Operating profit as a percentage of revenue — after production plus running costs, before interest and tax. 43.6%
Net margin Net margin Net profit as a percentage of revenue — what remains after every expense, including interest and tax. 35.0%
Dividend yield Dividend yield Annual dividend per share as a percentage of the current share price. 0.6%
Technical signals
Based on daily closes
RSI (14) RSI (14) Relative Strength Index: momentum on a 0–100 scale, from the size of recent gains versus losses. Readings above 70 are conventionally called overbought and below 30 oversold — descriptions of recent price behaviour, not signals. 40.2Neutral range
50-day SMA 50-day SMA The average closing price over the last 50 trading days — a common medium-term trend reference. Price above it is often described as short-term strength. 1150.85Price below
200-day SMA 200-day SMA The average closing price over the last 200 trading days, used as a long-term trend reference. 1027.78Price above
50 vs 200 SMA 50 vs 200 SMA Compares the 50-day and 200-day averages. The 50 rising above the 200 is nicknamed a "golden cross"; falling below is a "death cross". Both are descriptions of past price, not forecasts. 50 > 200Golden cross pattern
MACD (12,26,9) MACD (12,26,9) Moving Average Convergence Divergence: the gap between the 12-day and 26-day exponential moving averages, compared against a 9-day signal line. Used to describe momentum shifts. -1.08Below signal line
MACD histogram MACD histogram The MACD line minus its signal line. Positive means MACD sits above the signal line; the bar size shows the gap. -10.80Negative
Technical indicators describe past price behaviour. They are not investment advice.
Short interest Short interest The number of shares that have been sold short — borrowed and sold by investors betting the price will fall — usually quoted as a share of all shares outstanding. Exchanges collect it twice a month at settlement, so the figure lags by a couple of weeks. Below about 2% is unremarkable; above 20% puts a company among the most heavily shorted on the market. It describes how much money is positioned against the company, not what the share price will do: shorts are sometimes right, and a crowded short sometimes unwinds violently upward.
Shares sold short · reported twice monthly
Low
Of shares outstanding1.15%
Days to cover Days to cover Short interest divided by average daily trading volume — roughly how many days of normal trading it would take for every short position to be bought back. It measures how thin the exit is. A large short position in a heavily traded stock can unwind in a day or two; the same position in a quiet stock can take weeks, which is what makes a rush for the exit disorderly. 4.1
vs 3 months ago+0.24pp
Daily volume sold short41%
Short interest is reported to the exchanges at settlement, twice a month, so the headline figure lags by a couple of weeks. The daily share of volume sold short is current but noisier — much of it is market-maker hedging that never becomes a lasting position. Neither figure predicts direction.